NCT06118203View on ClinicalTrials.gov

Semaglutide Use in Acute Pulmonary Embolism

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

January 2, 2022

Primary Completion Date

March 4, 2023

Study Completion Date

March 5, 2023

Conditions
Pulmonary Embolism
Interventions
DRUG

Semaglutide

Semaglutide in addition to standard of care

Trial Locations (1)

SW3 6NP

Colm McCabe, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT06118203 - Semaglutide Use in Acute Pulmonary Embolism | Biotech Hunter | Biotech Hunter